Skip to main content
TipRanks
Go Ultimate75% OFF

Top Glove Bhd (TGLVY) AI Stock Analysis

57 Followers
TGLVY

Top Glove Bhd

(Other OTC:TGLVY)

Select Model
Rating:69Neutral
Price Target:$1.00â–²(7.07% Upside)
Action:reiterated
Date:10/08/26

The overall score of 69 reflects a company in a solid financial recovery with a very strong balance sheet, which is the most significant positive factor. This is tempered by overbought technical conditions that introduce near-term risk and a valuation that is fair but not compelling. The recovery is on track, but the stock's recent strong run may have gotten ahead of fundamentals.

Positive Factors
Profitability recoveryThe return to solid profitability alongside renewed revenue growth indicates that the business has moved beyond its recent trough. Sustained positive margins can rebuild internal funding capacity, support operational investment, and strengthen resilience over the next several quarters.
Negative Factors
Pronounced earnings cyclicalityThe sharp swing from pandemic-era profits to later losses shows that earnings remain highly sensitive to industry demand and pricing conditions. This cyclicality makes recent recovery profits less predictable and can complicate capacity planning, investment decisions, and shareholder returns.

Top Glove Bhd (TGLVY) vs. SPDR S&P 500 ETF (SPY)

-20%0%20%40%60%80%TGLVY+73.28%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.87B
Dividend Yield
0.50%
Average Volume (3M)
1,711
Price to Earnings (P/E)
24.2
Beta (1Y)
-0.24
Revenue Growth
30.02%
EPS Growth
203.20%
Country
US
Employees
10,600
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Top Glove Bhd Business Overview & Revenue Model

Company Description

Founded in Shah Alam, Malaysia, in 1991, Top Glove Corporation Bhd. primarily operates as an investment holding company, offering comprehensive management services. The company is a major manufacturer, specializing in a wide array of gloves, includin...

How the Company Makes Money

Top Glove primarily makes money by manufacturing disposable gloves and selling them to customers in domestic and international markets. Revenue is generated from (1) sales of glove products across different material types (e.g., natural rubber latex...

Top Glove Bhd Financial Statement Overview

Summary

Financial performance is solid, driven by a synchronized recovery. The balance sheet is a fortress with a 0.17 debt-to-equity ratio. Cash flow has rebounded strongly with a 0.79 free cash flow conversion ratio. The income statement shows a return to profitability, though margins remain a fraction of peak levels, indicating a still-fragile recovery.

Income Statement

72Positive

Balance Sheet

85Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMAug 2026Aug 2025Aug 2024Aug 2023Aug 2022
Income Statement
Total Revenue4.24B4.05B3.49B2.51B2.26B5.57B
Gross Profit2.22B389.07M89.01M265.32M64.32M953.38M
EBITDA715.55M696.52M455.66M266.09M-544.66M711.00M
Net Income307.50M294.90M132.18M-18.27M-878.61M275.73M
Balance Sheet
Total Assets6.69B6.69B6.27B6.96B7.06B8.12B
Cash, Cash Equivalents and Short-Term Investments978.20M978.20M560.67M933.23M942.82M946.75M
Total Debt852.95M852.95M849.86M422.09M581.85M417.07M
Total Liabilities1.69B1.69B1.49B1.12B1.14B1.32B
Stockholders Equity4.97B4.97B4.76B5.81B5.89B6.75B
Cash Flow
Free Cash Flow324.53M415.97M156.31M-122.54M-244.10M-774.72M
Operating Cash Flow423.76M529.12M300.16M20.70M121.04M178.81M
Investing Cash Flow-324.78M-413.57M450.90M247.46M-383.26M132.42M
Financing Cash Flow-26.20M-30.38M-803.47M-181.66M94.75M-740.35M

Top Glove Bhd Technical Analysis

Technical Analysis SentimentPositive
Last Price0.93

Price Trends

50DMA0.79Positive
100DMA0.70Positive
200DMA0.68Positive

Market Momentum

MACD0.03Positive
RSI58.76Neutral
STOCH36.20Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TGLVY, the sentiment is Positive. The current price of 0.93 is above the 20-day moving average (MA) of 0.88, above the 50-day MA of 0.79, and above the 200-day MA of 0.68, indicating a bullish trend. The MACD of 0.03 indicates Positive momentum. The RSI at 58.76 is Neutral, neither overbought nor oversold. The STOCH value of 36.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TGLVY.

Top Glove Bhd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TGLVY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TGLVYTGLVY69Neutral$1.82B24.226.39%0.50%30.02%203.20%
MDLNMDLN65Neutral$49.57B56.524.97%―11.85%-57.19%
ICUIICUI64Neutral$4.42B74.272.81%―-5.82%―
BDXBDX63Neutral$58.68B52.054.64%1.85%-7.40%-28.89%
BAXBAX58Neutral$13.33B-18.63-11.62%0.16%5.33%-164.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SOLVSOLV50Neutral$14.61B97.473.18%―-3.09%-89.72%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%60%TGLVYBAXBDXICUISOLVMDLNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TGLVY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TGLVYTop Glove Corporation0.930.3867.99%
BAXBaxter International Inc25.768.1145.91%
BDXBecton, Dickinson and Co215.4268.8146.94%
ICUIICU Medical176.9144.3433.45%
SOLVSolventum Corporation86.068.7511.32%
MDLNMedline, Inc. Class A37.68-3.32-8.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 08, 2026